摘要
目的 探讨SF 36量表应用于血透患者生活质量研究的可行性。方法 采用整群抽样法 ,用SF 36量表对杭州市 4家血透中心的 1 81例血透患者进行自评量表式调查。参照国际生命质量评价项目的标准 ,进行信度、效度与反应度的测试。结果 SF 36量表的分半信度是 0 .91 ,8个维度的Cronbachα系数范围为 0 .56～ 0 .90。除了PF维度 ,各维度的集合效度和区分效度成功率均为 1 0 0 %。因子分析产生两个主成分 ,分别代表生理健康和心理健康 ,解释了 69.4%的总方差。SF 36量表总分与世界卫生组织生存质量测定量表总分以及患者自我总体健康评价得分的相关性分别为 0 .85和 0 .76。患者接受血透治疗后 ,PF、RP、BP、VT和SF维度得分显著提高。结论 SF
Objective To study the feasibility of measuring health status for hemodialysis patients with end stage renal disease by the SF 36 scales. Methods By a cluster sampling procedure, 181 hemodialysis patients, from 4 hemodialysis centers in Hangzhou, completed the SF 36 scales by self administration. The reliability, validity and responsiveness were tested according to the standard procedure of the International Quality of Life Assessment Project. Results The split half reliability coefficient of the SF 36 was 0.91 and the Cronbach α coefficients of the eight scales ranged from 0.56 to 0.90. The scaling success rates on both convergent validity and discriminative validity were 100% for all scales except PF. Factor analysis identified two principal components which were a physical factor and a mental factor. They could be used to explain 69.4% of the total variance. The correlation coefficient of the total score between the SF 36 and the WHOQOL BREF was 0.85, and that between the SF 36 and the patients' self reported quality of life was 0.76. After the therapy, the scores of PF, RP, BP, VT and SF increased significantly. Conclusion The SF 36 scales satisfied the psychometric scaling assumptions well enough to warrant wide use in Chinese hemodialysis patients.
出处
《中国行为医学科学》
CSCD
2003年第1期31-33,共3页
Chinese Journal of Behavioral Medical Science
基金
浙江省科技计划项目 ( 99110 4 2 0 9)
